Evidence map›Paper›PMID 38032361›Full record

ArticleThe Journal of experimental medicine2024

Scaling up robust immunopeptidomics technologies for a global T cell surveillance digital network.

Saketh Kapoor, Loïze Maréchal, Isabelle Sirois, Étienne Caron

Abstract readLegal Case
In one paragraph

Article in The Journal of experimental medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Saketh Kapoor *Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.
Loïze Maréchal *CHU Sainte-Justine Research Center, Université de Montréal , Montreal, Canada.ORCID 0000-0003-0922-0061
Isabelle SiroisCHU Sainte-Justine Research Center, Université de Montréal , Montreal, Canada.
Étienne CaronDepartment of Immunobiology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0003-2770-6970

Funding

CIHR 174924
6 · The paper itself

Abstract

The human immunopeptidome plays a central role in disease susceptibility and resistance. In our opinion, the development of immunopeptidomics and other peptide sequencing technologies should be prioritized during the next decade, particularly within the framework of the Human Immunopeptidome Project initiative. In this context, we present bold ideas, fresh arguments, and call upon industrial partners and funding organizations to support and champion this important initiative that we believe has the potential to save countless lives in the future.

Indexed as

T-LymphocytesAmino Acid SequenceHumans

Identifiers

PMID38032361
PMCPMC10689202

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.